Dexcom (Nasdaq:DXCM) today unveiled its next-generation continuous glucose monitor (CGM), the G8 system, at its Investor Day ...

Glooko announced that the FDA granted 510(k) clearance for its EndoTool IV Cloud, a cloud-based, patient-specific insulin dosing platform.

Glooko and MyLife Diabetes Care announced today that they agreed to expand their partnership centered around diabetes management products. Under their agreement, Glooko serves as MyLife Diabetes ...

ViCentra announced today that it launched its Kaleido smartphone-controlled hybrid closed-loop insulin delivery system in ...

Sava Technologies today announced the appointment of John Bernard as its new chief commercial officer (CCO).